2024-09-27 CMN Live: CRISPR next frontier: in vivo editing of the microbiome

In this episode of CMN Live, CMN Editor-in-chief Karen O'Hanlon Cohrt chats with special guest Xavier Duportet (CEO, Eligo Bioscience) about the human microbiome, its role in health and disease, and how gene editing within the microbiome will open a whole new chapter in medicine.

 

 

2024-03-15 CMN Live: Detecting Colorectal Cancer Using CRISPR

CMN Editor-in-chief Karen O'Hanlon Cohrt speaks with special guest Daniel Worthley MD, PhD about the importance and challenge of detecting colorectal cancer, and the ways in which CRISPR might be part of a solution. Daniel Worthley is a cancer researcher and gastroenterologist at Colonoscopy Clinic in Queensland, Australia.

 

 

2024-01-26 CMN Live: Therapeutic gene editing. A lot done, a lot more to do

Watch the inaugural CMN Live discussion between CMN Editor-in-chief Karen O'Hanlon Cohrt, PhD O'Hanlon Cohrt and Eric B. Kmiec of ChristianaCare Gene Editing Institute and CorriXR Therapeutics. They discuss the successes and challenges of therapeutic gene editing.